- Home
- EBS vs CADL Comparison
EBS vs CADL Comparison
Compare EBS & CADL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EBS
- CADL
- Stock Information
- Founded
- EBS 1998
- CADL 1999
- Country
- EBS United States
- CADL United States
- Employees
- EBS N/A
- CADL N/A
- Industry
- EBS Biotechnology: Pharmaceutical Preparations
- CADL Biotechnology: Pharmaceutical Preparations
- Sector
- EBS Health Care
- CADL Health Care
- Exchange
- EBS Nasdaq
- CADL Nasdaq
- Market Cap
- EBS 359.3M
- CADL 313.5M
- IPO Year
- EBS 2006
- CADL 2021
- Fundamental
- Price
- EBS $8.15
- CADL $4.79
- Analyst Decision
- EBS Strong Buy
- CADL Strong Buy
- Analyst Count
- EBS 3
- CADL 5
- Target Price
- EBS $14.33
- CADL $19.80
- AVG Volume (30 Days)
- EBS 1.0M
- CADL 724.9K
- Earning Date
- EBS 11-05-2025
- CADL 08-14-2025
- Dividend Yield
- EBS N/A
- CADL N/A
- EPS Growth
- EBS N/A
- CADL N/A
- EPS
- EBS 2.53
- CADL N/A
- Revenue
- EBS $851,600,000.00
- CADL N/A
- Revenue This Year
- EBS N/A
- CADL N/A
- Revenue Next Year
- EBS $19.24
- CADL N/A
- P/E Ratio
- EBS $3.25
- CADL N/A
- Revenue Growth
- EBS N/A
- CADL N/A
- 52 Week Low
- EBS $4.02
- CADL $3.79
- 52 Week High
- EBS $12.73
- CADL $14.60
- Technical
- Relative Strength Index (RSI)
- EBS 51.40
- CADL 32.97
- Support Level
- EBS $7.45
- CADL $4.81
- Resistance Level
- EBS $8.62
- CADL $5.01
- Average True Range (ATR)
- EBS 0.40
- CADL 0.30
- MACD
- EBS -0.10
- CADL -0.08
- Stochastic Oscillator
- EBS 38.46
- CADL 3.18
About EBS Emergent Biosolutions Inc.
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. The key revenue is generated through the commercial segment which consists of NARCAN and other commercial products.
About CADL Candel Therapeutics Inc.
Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.